Articles tagged "Mortality"

2020 American Transplant Congress
Predictive Validity of Functional Status on Mortality in Adult Kidney Transplant Recipients
N. Chu, Z. Shi, D. Segev, M. McAdams Demarco
Johns Hopkins, Baltimore, MD
*Purpose: Frailty and disabilities, though not routinely measured, are highly prevalent in kidney transplant (KT) recipients and predict poor post-transplant outcomes. The Karnofsky Performance Scale…
2020 American Transplant Congress
Waitlist Mortality and Transplant Probability for Inactively Listed Liver Patients Depends on Donor Service Areas’ Median MELD at Transplant
R. Batra¹, S. Noreen², D. Stewart², D. Haakinson¹, G. Gan³, Y. Deng³, S. Kulkarni¹
¹Surgery, Yale University School of Medicine, New Haven, CT, ²UNOS, Richmond, VA, ³Yale University, New Haven, CT
*Purpose: Presently, the outcome of patients listed inactive on liver transplant waiting list (WL) are unknown; as inactive patients cannot receive deceased donor organ offers,…
2020 American Transplant Congress
MELD is MELD is MELD? Geographic/ Center-Level Variation in Mortality for Patients with the Same MELD Score
T. Ishaque¹, A. B. Massie¹, A. B. Kernodle¹, S. Getsin¹, P. Chaing¹, J. G. Jacqueline Garonzik Wang¹, S. Gentry², D. Segev¹
¹Johns Hopkins University, Baltimore, MD, ²Department of Mathematics, United States Naval Academy, Annapolis, MD
*Purpose: Waitlist candidates living in areas with poor access to health care may have higher mortality risk compared to candidates with same MELD in other…
2020 American Transplant Congress
The Impact of Initial Alpha-Fetoprotein >100 but <1,000 ng/mL and Pre-Transplant alpha-Fetoprotein Reduction on Outcomes after Liver Transplant in Patients with Hepatocellular Carcinoma
M. L. Goldman¹, K. Zhou², J. L. Dodge¹, F. Yao¹, N. Mehta¹
¹Department of Medicine, UCSF, San Francisco, CA, ²Department of Medicine, USC, Los Angeles, CA
*Purpose: Under current UNOS policy, hepatocellular carcinoma (HCC) patients with alpha-fetoprotein (AFP) >1,000 ng/mL are required to show a reduction in AFP to 100 but
2020 American Transplant Congress
Frailty Prior to Hospital Discharge Predicts Mortality after Cirrhosis-Related Admissions
M. Serper¹, S. Tao², P. Garren¹, D. Peyton¹, M. A. Dunn², K. Reddy¹, A. Gougol², A. Duarte-Rojo²
¹University of Pennsylvania, Philadelphia, PA, ²University of Pittsburgh, Pittsburgh, PA
*Purpose: Inpatient frailty assessment and its utility in clinical care is understudied in liver transplant (LT) candidates. Study objectives were to quantify physical frailty among…
2020 American Transplant Congress
The Relationship Between Frailty and Performance Status in Patients with Cirrhosis Awaiting Liver Transplantation
C. Q. Xu¹, F. Yao², Y. Mohamad², R. Wong², D. Kent², S. Seetharaman², Y. Srisengfa², J. C. Lai²
¹Department of Medicine, UCSF, San Francisco, CA, ²Division of Gastroenterology and Hepatology, Department of Medicine, UCSF, San Francisco, CA
*Purpose: Frailty—a multi-dimensional construct that encapsulates physical function, performance status, and nutritional status—has emerged as a critical determinant of mortality in patients with cirrhosis. Currently,…
2019 American Transplant Congress
Association of Pretransplant and Posttransplant 5-Tier Ratings with Candidate Mortality after Listing
A. Wey, S. Gustafson, N. Salkowski, B. Kasiske, M. Skeans, C. Schaffhausen, A. Israni, J. Snyder
SRTR, Minneapolis, MN
*Purpose: The OPTN Final Rule mandates the Scientific Registry of Transplant Recipients (SRTR) to publish understandable reports of transplant rate, waitlist mortality, and posttransplant outcomes.…
2019 American Transplant Congress
Variables Associated with Intracardiac Thrombus during Orthotopic Liver Transplant: A Retrospective Single-Center Study
M. Groose¹, J. Mezrich², L. Hammel¹
¹Department of Anesthesiology, University of Wisconsin, Madison, WI, ²Department of Surgery, University of Wisconsin, Madison, WI
*Purpose: Intracardiac thrombus (ICT) is an intraoperative complication during orthotopic liver transplantation (OLT) with high mortality. Patients with end stage liver disease have compromised coagulation…
2019 American Transplant Congress
Impact of the Pediatric End-Stage Liver Disease Growth Failure Threshold on Waitlist Mortality in Children Awaiting Liver Transplant
S. M. Swenson, J. P. Roberts, S. Rhee, E. R. Perito
University of California, San Francisco, San Francisco, CA
*Purpose: To examine the impact on waitlist mortality of Pediatric End-Stage Liver Disease (PELD)’s incorporation of growth failure (GF) as a threshold variable—present or absent…
2019 American Transplant Congress
The National Landscape of Heart Transplant Candidates with HIV
A. A. Shaffer¹, A. G. Thomas², D. L. Segev¹
¹Surgery & Epidemiology, Johns Hopkins University, Baltimore, MD, ²Epidemiology, University of North Carolina, Chapel Hill, NC
*Purpose: Heart disease is a leading cause of death for HIV+ individuals, and the number of HIV+ heart transplant (HT) recipients is growing. Although understanding…